Table 4 Spearman’s correlation analysis between illness perception, self-efficacy, adherence to medication treatment and quality of life in subjects with intermittent claudication

Timeline cyclic

−0.262

p-value

(0.004)

Consequences

0.190

p-value

(0.037)

−0.116

p-value

(0.204)

Personal control

−0.171

p-value

(0.062)

0.144

p-value

(0.116)

−0.170

p-value

(0.058)

Treatment control

−0.283

p-value

(0.002)

0.006

p-value

(0.945)

−0.103

p-value

(0.267)

0.469

p-value

(< 0.001)

Illness coherence

0.127

p-value

(0.176)

−0.146

p-value

(0.113)

−0.025

p-value

(0.783)

0.322

p-value

(< 0.001)

0.372

p-value

Emotional representations

0.005

p-value

(0.953)

0.103

p-value

(0.260)

0.488

p-value

(< 0.001)

−0.079

p-value

(0.379)

−0.043

p-value

(0.643)

−0.170

p-value

(0.063)

Self- efficacy

0.067

p-value (0.484)

0.085

p-value (0.368)

−0137

p-value

(0.142)

0.074

p-value (0.432)

−0.081

p-value (0.394)

−0.130

p-value (0.165)

0.072

p-value

(0.427)

Adherence to treatment

−0.239

p-value (0.009)

−0.188

p-value (0.042)

−0.084

p-value

(0.356)

−0.183

p-value

(0.044)

0.224

p-value

(0.016)

0.205

p-value

(0.028)

−0.577

p-value

(< 0.001)

−0.057

p-value

(0.540)

Quality of life

−0.175

p-value (0.057)

0.076

p-value (0.415)

−0.568

p-value

(< 0.001)

0.348

p-value

(< 0.001)

0.114

p-value (0.238)

−0.010

p-value (0.917)

−0.108

p-value

(0.243)

0.224

p-value (0.014)

−0.224

p-value (0.013)